Biological Information
Background Information:
Phosphorylase kinase (Phk) is a complex enzyme consisting of four different subunits, (abgd)4, and isoforms or splice variants exist for each subunit. A muscle specific form of Phk deficiency is caused by mutations in the gene for the muscle isoform of the a subunit, PHKA1, whereas liver Phk deficiency can be caused by mutations in three genes: PHKA2, PHKB, and PHKG2. PHKB mutations cause autosomal recessive Phk deficiency of both liver and muscle, but liver symptoms predominate and the biochemical muscle involvement is often not clinically apparent. Ten different mutations in the PHKB gene have been identified in seven patients. PHKG2, also autosomal, encodes the testis/liver isoform of the catalytic g subunit. PHKG2 is a serine/threonine kinase that plays an important role in glycogen metabolism. Inhibition of PHKG2 may result in recurrent hypoglycemia, liver fibrosis and increased risk of cirrhosis.
Family:
Kinase
Sub Family:
CAMK
Class:
Protein Ser/Thr
Protein Name:
PHKG2
Uniprot Number:
P15735
Protein Aliases:
PHK-gamma-T|PSK-C3|Phosphorylase kinase subunit gamma-2
Gene Name:
PHKG2
Gene ID:
5261
Accession Number:
NM_000294
Organism:
Human
Construct Details:
Full Length, Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Human recombinant protein kinase PHKG2 expressed in insect Sf9 cells is used. Test compound and/or vehicle is preincubated with 0.364 μg/ml enzyme‡ in modified MOPS buffer pH 7.2 for 15 minutes at 37⁰C. The reaction is initiated by addition of 50 μM ZIPtide, 10 μM ATP and 0.25 μCi [γ32P]ATP for another 30 minute incubation period and terminated by further addition of 3% H3PO4. An aliquot is removed and counted to determine the amount of [32P]ZIPtide formed. Compounds are screened at 10 μM.
Substrate:
50 µM ZIPtide
ATP Concentration:
10 uM
Incubation:
30 min at 37°C
Control Inhibitor:
Staurosporine
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Metabolic Diseases
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS